|Articles|August 1, 2018
- BioPharm International-08-01-2018
- Volume 31
- Issue 8
BioPharm International, August 2018 Issue (PDF)
Click the title above to open the BioPharm International August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
The Search for Next-Gen Expression Systemsover 7 years ago
FDA Is Not Playing Games with Biosimilarsover 7 years ago
Expectations for Residual Impurity Analysis Continue to Riseover 7 years ago
E&L Risk Assessment for Biologic Drug Productsover 7 years ago
Submitting Extractables and Leachables Data to Regulatorsover 7 years ago
A New Paradigm in Drug Developmentover 7 years ago
Maintaining Cell Line Integrityover 7 years ago
FDA Seeks to Revive Quality Metrics InitiativeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
4
Scaling up viral vector harvest with ease and regulatory compliance
5
